389 related articles for article (PubMed ID: 28937221)
1. In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions.
Koenigsknecht MJ; Baker JR; Wen B; Frances A; Zhang H; Yu A; Zhao T; Tsume Y; Pai MP; Bleske BE; Zhang X; Lionberger R; Lee A; Amidon GL; Hasler WL; Sun D
Mol Pharm; 2017 Dec; 14(12):4295-4304. PubMed ID: 28937221
[TBL] [Abstract][Full Text] [Related]
2. Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions.
Bermejo M; Paixão P; Hens B; Tsume Y; Koenigsknecht MJ; Baker JR; Hasler WL; Lionberger R; Fan J; Dickens J; Shedden K; Wen B; Wysocki J; Löbenberg R; Lee A; Frances A; Amidon GE; Yu A; Salehi N; Talattof A; Benninghoff G; Sun D; Kuminek G; Cavanagh KL; Rodríguez-Hornedo N; Amidon GL
Mol Pharm; 2018 Dec; 15(12):5454-5467. PubMed ID: 30372084
[TBL] [Abstract][Full Text] [Related]
3. Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 2: Fed State.
Paixão P; Bermejo M; Hens B; Tsume Y; Dickens J; Shedden K; Salehi N; Koenigsknecht MJ; Baker JR; Hasler WL; Lionberger R; Fan J; Wysocki J; Wen B; Lee A; Frances A; Amidon GE; Yu A; Benninghoff G; Löbenberg R; Talattof A; Sun D; Amidon GL
Mol Pharm; 2018 Dec; 15(12):5468-5478. PubMed ID: 30417648
[TBL] [Abstract][Full Text] [Related]
4. Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs.
Hens B; Tsume Y; Bermejo M; Paixao P; Koenigsknecht MJ; Baker JR; Hasler WL; Lionberger R; Fan J; Dickens J; Shedden K; Wen B; Wysocki J; Loebenberg R; Lee A; Frances A; Amidon G; Yu A; Benninghoff G; Salehi N; Talattof A; Sun D; Amidon GL
Mol Pharm; 2017 Dec; 14(12):4281-4294. PubMed ID: 28737409
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal and Systemic Disposition of Diclofenac under Fasted and Fed State Conditions Supporting the Evaluation of in Vitro Predictive Tools.
Van Den Abeele J; Schilderink R; Schneider F; Mols R; Minekus M; Weitschies W; Brouwers J; Tack J; Augustijns P
Mol Pharm; 2017 Dec; 14(12):4220-4232. PubMed ID: 28621952
[TBL] [Abstract][Full Text] [Related]
6. Application of the GastroDuo to study the interplay of drug release and gastric emptying in case of immediate release Aspirin formulations.
Schick P; Sager M; Voelker M; Weitschies W; Koziolek M
Eur J Pharm Biopharm; 2020 Jun; 151():9-17. PubMed ID: 32268191
[TBL] [Abstract][Full Text] [Related]
7. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
Rubbens J; Brouwers J; Tack J; Augustijns P
Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
[TBL] [Abstract][Full Text] [Related]
9. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
10. Gastric emptying and intestinal appearance of nonabsorbable drugs phenol red and paromomycin in human subjects: A multi-compartment stomach approach.
Paixão P; Bermejo M; Hens B; Tsume Y; Dickens J; Shedden K; Salehi N; Koenigsknecht MJ; Baker JR; Hasler WL; Lionberger R; Fan J; Wysocki J; Wen B; Lee A; Frances A; Amidon GE; Yu A; Benninghoff G; Löbenberg R; Talattof A; Sun D; Amidon GL
Eur J Pharm Biopharm; 2018 Aug; 129():162-174. PubMed ID: 29857136
[TBL] [Abstract][Full Text] [Related]
11. Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract.
Yu A; Baker JR; Fioritto AF; Wang Y; Luo R; Li S; Wen B; Bly M; Tsume Y; Koenigsknecht MJ; Zhang X; Lionberger R; Amidon GL; Hasler WL; Sun D
Mol Pharm; 2017 Feb; 14(2):345-358. PubMed ID: 28009518
[TBL] [Abstract][Full Text] [Related]
12. Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms.
Lex TR; Rodriguez JD; Zhang L; Jiang W; Gao Z
AAPS J; 2022 Mar; 24(2):40. PubMed ID: 35277760
[TBL] [Abstract][Full Text] [Related]
13. Scintigraphic evaluation of the in vivo performance of dry-coated delayed-release tablets in humans.
Kambayashi A; Sako K; Kondo H
Eur J Pharm Biopharm; 2020 Jul; 152():116-122. PubMed ID: 32380166
[TBL] [Abstract][Full Text] [Related]
14. Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state.
Mudie DM; Murray K; Hoad CL; Pritchard SE; Garnett MC; Amidon GL; Gowland PA; Spiller RC; Amidon GE; Marciani L
Mol Pharm; 2014 Sep; 11(9):3039-47. PubMed ID: 25115349
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution.
Yu A; Koenigsknecht MJ; Hens B; Baker JR; Wen B; Jackson TL; Pai MP; Hasler W; Amidon GL; Sun D
AAPS J; 2019 Nov; 22(1):3. PubMed ID: 31712917
[TBL] [Abstract][Full Text] [Related]
16. Factors Affecting Successful Extrapolation of Ibuprofen Exposure from Adults to Pediatric Populations After Oral Administration of a Pediatric Aqueous Suspension.
Statelova M; Holm R; Fotaki N; Reppas C; Vertzoni M
AAPS J; 2020 Nov; 22(6):146. PubMed ID: 33184711
[TBL] [Abstract][Full Text] [Related]
17. Exploring the impact of real-life dosing conditions on intraluminal and systemic concentrations of atazanavir in parallel with gastric motility recording in healthy subjects.
Hens B; Masuy I; Deloose E; Mols R; Tack J; Augustijns P
Eur J Pharm Biopharm; 2020 May; 150():66-76. PubMed ID: 32113916
[TBL] [Abstract][Full Text] [Related]
18. Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.
Salehi N; Kuminek G; Al-Gousous J; Sperry DC; Greenwood DE; Waltz NM; Amidon GL; Ziff RM; Amidon GE
Mol Pharm; 2021 Sep; 18(9):3326-3341. PubMed ID: 34428047
[TBL] [Abstract][Full Text] [Related]
19. Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection.
Gajewska M; Blumenstein L; Kourentas A; Mueller-Zsigmondy M; Lorenzo S; Sinn A; Velinova M; Heimbach T
AAPS J; 2020 Oct; 22(6):134. PubMed ID: 33070288
[TBL] [Abstract][Full Text] [Related]
20. The biorelevant simulation of gastric emptying and its impact on model drug dissolution and absorption kinetics.
Vrbanac H; Trontelj J; Berglez S; Petek B; Opara J; Jereb R; Krajcar D; Legen I
Eur J Pharm Biopharm; 2020 Apr; 149():113-120. PubMed ID: 32057907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
